AesculaTech engages in the development and manufacture of a platform of devices for the treatment of diseases for the eye.
Blumio is designing a sensor that can measure blood pressure noninvasively and continuously. Our initial focus is to deliver a product that can "close the loop" in the management of hypertension. Website
First gas-based therapy for fungal nail infections. We are a 5 person team of very experienced technicians. Our medical device prototype is currently in two ongoing clinical trials.
Green Sun Medical was founded to develop innovative treatments to address adolescent idiopathic scoliosis and kyphosis. We are developing a dynamic orthotic that will aid in treating these spinal deformities. Website
We have developed a safe, completely noninvasive monitor of fetal oxygenation in utero. The standard of care for fetal monitoring is nonspecific, leading to >400,000 unnecessary C-sections per year. Website
Siris's novel machine learning software enables faster cancer treatment planning (saving time/cost) and insights enabling improved outcomes for cancer patients. Website
Zenflow is developing the Spring System, a novel minimally invasive therapy designed to relieve urinary obstruction related to BPH (enlarged prostate). Website
We are changing the way EEG is done at hospitals. Our product is a zero-prep, dry electrode headset backed by a cloud that offers live upload, tools for analysis & remote interpretation by neurologists. Website
Abreos Biosciences is developing laboratory-based and point-of-care tests for precision dosing of biologic drugs, which will improve outcomes, minimize side effects, and reduce costs.
Cayuga Biotech is a startup spun out of Galen Stucky’s laboratory at UCSB to develop novel materials that stop uncontrollable hemorrhage and save lives by reaching currently unmet patient populations.
CHO Plus creates genetically-engineered mammalian cells to be used for therapeutic protein manufacturing. Engineered cells exhibit 4.5-fold higher productivity than parent cells in our model system.
Correlia Bio is developing next generation fully automated protein testing platforms to conserve precious samples and increase speed for pharma, life science research, and personalized medicine..
The first diagnostic for endometriosis, which affects 1 in 10 women and is a leading cause of infertility and chronic pain. Today, the diagnostic standard for the disease is surgery.
Encellin has developed a patented ultra thin-film implantable cell delivery system to promote and protect enclosed cell function. We will address the severe hypoglycemic episodes of type 1 diabetics.
Epalex is a spin-off of the University of California, Davis that has licensed technology to a breakthrough treatment for seizure clusters and migraine headache.
Palisade Therapeutics is a new venture with a novel therapeutic approach for treating age-related dementia, an unmet, emerging clinical market with a value estimated at $20 billion.
‘Kill and replace’ approach to bacterial disease as alternative to antibiotics. Engineered phage kills only the pathogen, and probiotic replaces it to balance the microbiome. First indication is acne.
SpineOvations, Inc. is a Southern California-based medical device company developing novel, minimally invasive therapies for lower back pain and spinal/disc diseases.